Anges.Inc, the Japanese developer of DNA-vaccine against coronavirus, proceeded to the clinical trials on two groups consisting of 30 volunteers as kyodonews reported.

The first part of the clinical trials consists of the vaccination of 30 healthy volunteers. It is planned to open the sale of the vaccines in autumn 2021 if it is safe and efficient.

The trials will last eight days. One group of 15 people will get more vaccines than the other one. Each person will get two intramuscular injections.

Related: Russia ready to supply vaccine against coronavirus to world markets

The registered person will be observed until July 2021.

As we reported, Israel will receive the first vaccines against coronavirus in December; the respective contract is already signed. We are talking about vaccines, the development of which is at the final stage of clinical trials. The first stage to verify the safety of the drug was completed successfully, and the second stage was completed recently.


Source link